PerkinElmer Advances in Chinese Market - - Chromatography Online
PerkinElmer Advances in Chinese Market

LCGC Europe eNews

PerkinElmer (Massachusetts, USA) has announced the acquisition of Haoyuan Biotech (Shanghai, China), an infectious disease diagnostics company, for the reported amount of $38 million. The acquisition promises to advance the clinical diagnostics capabilities of PerkinElmer, establishing their foothold on the rapidly growing Chinese market.

Haoyan Biotech focuses on the delivery of molecular diagnostics used within blood bank and clinical settings in China. The acquisition will result in the addition of four diagnostic assays to PerkinElmer’s portfolio that are approved by China’s state Food and Drug Administration (SFDA).

"By combining PerkinElmer's robust disease-screening capabilities with Haoyuan's proprietary reagents and equipment, the company will be able to offer highly sensitive systems and assays for quality detection of blood-borne infections for the Chinese market," commented Robert Friel, chairman and chief executive officer of PerkinElmer. "Integrating Haoyuan's screening products with PerkinElmer's diagnostics capabilities will help to further advance the health of the Chinese people by offering leading technology that ensures accurate diagnosis of infectious diseases at a low cost."

For more information please visit:

www.perkinelmer.co.uk

ADVERTISEMENT

LCGC E-mail Newsletters
Global E-newsletters subscribe here:




 
Survey
CHROMacademy
Are you aware of CHROMacademy and the learning tools it offers?
Yes, I would like to know more
Yes, I am not interested
No, I would like to know more
No, I am not interested
Yes, I would like to know more
69%
Yes, I am not interested
9%
No, I would like to know more
16%
No, I am not interested
6%
View Results

LCGC COLUMNISTS 2014

Column Watch | Ronald E. Majors: Ron Majors, established authority on new column technologies, keeps readers up-to-date with new sample preparation trends in all branches of chromatography and reviews developments. LATEST: Standardized Testing of Silica as a Base Material for Difficult Bonded-Phase Preparative Applications


Perspectives in Modern HPLC: Michael W. Dong is a senior scientist in Small Molecule Drug Discovery at Genentech in South San Francisco, California. He is responsible for new technologies, automation, and supporting late-stage research projects in small molecule analytical chemistry and QC of small molecule pharmaceutical sciences. LATEST: Seven Common Faux Pas in Modern HPLC


MS — The Practical Art: Kate Yu brings her expertise in the field of mass spectrometry and hyphenated techniques to the pages of LCGC. In this column she examines the mass spectrometric side of coupled liquid and gas-phase systems. Troubleshooting-style articles provide readers with invaluable advice for getting the most from their mass spectrometers. LATEST: Radical Mass Spectrometry as a New Frontier for Bioanalysis


LC Troubleshooting: LC Troubleshooting sets about making HPLC methods easier to master. By covering the basics of liquid chromatography separations and instrumentation, John Dolan is able to highlight common problems and provide remedies for them. LATEST: How Much Retention Time Variation Is Normal?


More LCGC Chromatography-Related Columnists>>

LCGC North America Editorial Advisory Board>>

LCGC Europe Editorial Advisory Board>>

LCGC Editorial Team Contacts>>


Source: LCGC Europe eNews,
Click here